作者: AbdulRazaq Sokoro , Leigh Anne Shafer , Mitchell Darr , Harminder Singh
DOI: 10.1016/J.CCA.2019.10.017
关键词:
摘要: Abstract Background Guaiac fecal occult blood testing (gFOBT) is often used “off-label” for gastrointestinal (GI) bleeding. Fecal Immunochemical Test (FIT) increasingly replacing gFOBT in colorectal cancer screening and may play a role assessment significant bowel disease. We examined the concordance of FIT with (Hemoccult Sensa II) among inpatients between day 1 3 results. Methods was performed alongside on all inpatient stool sent to Winnipeg Health Sciences Centre laboratory over y. days post collection, while only. Results Positivity rates were highest Day (27.7%), lowest (18.3%). Concordance Days negative test results (96.4% 94.1%) significantly higher than that expected by chance alone (58.7% 61.3%, P Conclusions found no benefit delayed 3 days collection. provides equivalent hospitalized patients.